Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ESMO and IARC have joined forces to improve cancer prevention worldwide.

ESMO is supporting IARC in the development of their online learning platform which integrates all research for cancer prevention in one easy-to-access point.

ESMO-Cancer-Prevention-1000x1000-World-Cancer-Report

IARC’s  World Cancer Report Updates Learning Platform offers freely accessible learning material based on selected content from the IARC 2020 World Cancer Report, the most comprehensive resource on cancer prevention published every five years. The goal of the platform is to turn the latest research into policy and practical measures to help stakeholders in control cancer. It is also designed to enlarge the base of doctors who are properly educated and trained in key prevention measures, allowing them to provide guidance to patients as well as to act as role models.

As this is a freely accessible resource, with vital information on cancer prevention and research, ESMO would encourage you to register for the portal, by clicking on the banner below in order to receive direct updates.

Upcoming webinar: 

Social inequalities and cancer - Thursday 21 January 18:00-19:00 CET.

Register here

Access to on demand webinars:

ESMO-Cancer-Prevention-1000x1000-Obesity-Webinar
ESMO-Cancer-Prevention-1000x1000-HPV-Vaccination-Webinar

About the IARC World Cancer Report

The IARC 2020 World Cancer Report: Cancer Research for Cancer Preventionnotes that cancer is the ‘first or second cause of premature death (ages 30-69) in 134 of 183 countries’.

According to the IARC Global Cancer Observatory  cancer is expected to increase from 2018 to 2040, from an incidence of 18.1 million to 29.5 million with growth in the number of deaths from 9.6 million to 16.4 million. A main message of the IARC report is that prevention offers the most cost-effective long-term strategy for the control of cancer. The report offers a wealth of knowledge including ‘the most comprehensive overview of relevant research available to date, ranging from descriptive etiology, cellular and molecular biology, toxicology and pathology through to behavioural and social science. Key chapters include discussions on the impact of inequalities in cancer, vaccination and screening, genomic individual susceptibility to cancer and the finer identification of those at risk, which may allow ‘precision cancer prevention’.’ The section on ‘inequalities that affect cancer prevention’ is new in the 2020 edition and explains how socioeconomic inequalities can limit cancer prevention impact. The IARC report is complemented by other publications such as the  WHO Classification of Tumours series (also known as the WHO Blue Books); the IARC volumes of Cancer Incidence in Five Continents, and the associated GLOBOCAN database document data on incidence, prevalence, mortality, and trends for multiple cancer types accessible online through the IARC Global Cancer Observatory.

The IARC report provides the most up-to-date science on cancer, and was published at the same time as the WHO 2020 Report on Cancer: setting priorities, investing wisely and providing care for all which indicates how that science can be translated into public policies.

The WHO and IARC reports provide a reliable resource for ESMO members for evidence-based data on the burden of cancer, its prevention, and public policy recommendations governments and health authorities can implement to save lives.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings